4.8 (350) · $ 5.99 · In stock
The outlook is good, but barriers to optimal treatment remain
Clinical Challenges articles page [6]
European Commission Approves RINVOQ® (upadacitinib) for the Treatment of Adults With Moderate to Severe Ulcerative Colitis - Jul 26, 2022
Clinical Challenges articles page [6]
Stem Cell Therapy for Inflammatory Bowel Disease: Advancements & Limitations
Microorganisms, Free Full-Text
C. diff: What It Is, Symptoms, How It's Spread & Treatment
Ulcerative Colitis: Today, Tomorrow, and the Future - European Medical Journal
Fevers With Crohn's and Colitis: Causes and Management
Ulcerative colitis - Diagnosis and treatment - Mayo Clinic
What to Know About Crohn's Disease and Colitis
Ulcerative Colitis Surgery: Types, Recovery, Aftercare
Clinical Challenges articles page [6]
Ulcerative Colitis Diagnosis and Testing: How It Works